<p>What is described is an aqueous pharmaceutical formulation for intranasal delivery of liraglutide, comprising liraglutide, a solubilizing agent, and a chelating agent; a dosage form comprising the formulation; and a method of using such formulation for treating metabolic diseases in a mammal. Also described is a method for treating metabolic diseases in a mammal comprising administering intranasally a liraglutide formulation comprises a therapeutically effective amount of liraglutide and one or more excipients selected from the group consisting of a solubilizing agent and a chelating agent.</p>
申请公布号
WO2007146448(A1)
申请公布日期
2007.12.21
申请号
WO2007US60517
申请日期
2007.01.12
申请人
NASTECH PHARMACEUTICAL COMPANY INC.;KLEPPE, MARY, S.;LI, CHING-YUAN;TEMPLIN, MICHAEL, V.
发明人
KLEPPE, MARY, S.;LI, CHING-YUAN;TEMPLIN, MICHAEL, V.